Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause

2025-08-07 07:30:00 ET

Investment Thesis

I grant Bio-Rad Laboratories ( BIO ) a Hold rating. I consider that the environment of macroeconomic uncertainty that the company faces is a reason to be cautious. The Government is pressuring biopharmaceutical companies to lower the selling prices of their medicines. In addition, it plans to cut the budget allocated to the U.S. National Institutes of Health [NIH] by 40% in 2026 on an annual basis. Furthermore, it expects to implement other significant cuts to the U.S. public healthcare system. All these decisions are expected to have an adverse effect on Bio-Rad's revenues....

Read the full article on Seeking Alpha

For further details see: